HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat.

Abstract
We improved medial collateral ligament (MCL) healing throughout 90 days after surgical transection. We introduced intraperitoneal, per-oral (in drinking water) and topical (thin cream layer) peptide therapy always given alone, without a carrier. Previously, as an effective peptide therapy, stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, an anti-ulcer peptide effective in inflammatory bowel disease therapy (PL 14736)) particularly improved healing of transected tendon and muscle and wound healing effect including the expression of the early growth response 1 (egr-1) gene. After MCL transection BPC 157 was effective in rats when given once daily intraperitoneally (10 microg or 10 ng/kg) or locally as a thin layer (1.0 microg dissolved in distilled water/g commercial neutral cream) at the site of injury, first application 30 min after surgery and the final application 24 h before sacrifice. Likewise, BPC 157 was effective given per-orally (0.16 microg/ml in the drinking water (12 ml/day/rat)) until sacrifice. Commonly, BPC 157 microg-ng-rats exhibited consistent functional, biomechanical, macroscopic and histological healing improvements. Thus, we suggest BPC 157 improved healing of acute ligament injuries in further ligament therapy.
AuthorsTomislav Cerovecki, Ivan Bojanic, Luka Brcic, Bozo Radic, Ivan Vukoja, Sven Seiwerth, Predrag Sikiric
JournalJournal of orthopaedic research : official publication of the Orthopaedic Research Society (J Orthop Res) Vol. 28 Issue 9 Pg. 1155-61 (Sep 2010) ISSN: 1554-527X [Electronic] United States
PMID20225319 (Publication Type: Journal Article)
Copyright(c) 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
Chemical References
  • Collagen Type I
  • Collagen Type III
  • Peptide Fragments
  • Proteins
  • BPC 157
Topics
  • Administration, Oral
  • Animals
  • Collagen Type I (metabolism)
  • Collagen Type III (metabolism)
  • Contracture (prevention & control)
  • Disease Models, Animal
  • Male
  • Medial Collateral Ligament, Knee (drug effects, injuries, physiology)
  • Motor Activity (drug effects)
  • Neutrophils (physiology)
  • Peptide Fragments (pharmacology)
  • Proteins (pharmacology)
  • Rats
  • Rats, Wistar
  • Recovery of Function (drug effects)
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: